ArpanaIyengar IndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE

Dr Arpana Iyengar is a clinician researcher and professor of pediatric nephrology at St John’s Medical College Hospital, Bangalore. Her work focuses on renal nutrition and chronic kidney disease. She is one among the few in low- and middle-income countries to have been awarded with a PhD in pediatric nephrology. She has conducted cohort studies and randomized trials, secured research grants, and served as an associate editor of the Indian Journal of Nephrology. She has led the ISN’s Clinical Research Program (2019-2023), chaired the ISN Mentorship Program (2019-2024), and convened the ISN’s Scientific Writing Course, training nephrologists globally in clinical pediatric nephrology, research and manuscript writing. She is also a member of the Saving Young Lives committee and the IPNA Clinician Scientist Academy.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/b9a2272d1e177a89c1955a0950657894.jpg

First name

Arpana

Last name

Iyengar

Institution

Country

India

Saturday, February 8, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Making the Case: Investing in Kidney Care for Equity and Access BKH04 AKBhalla Chair bhallaak@yahoo.comIndiaSir Ganga Ram Hospital New Delhi ElenaZakharova Chair helena.zakharova@gmail.comRussiaElena Zakharova, Botkin Hospital, Moscow, Russia MarinaWainstein Chair marinawainstein@outlook.comArgentinaAcademia Nacional de Medicina de Buenos Aires Empowering Kidney Care Through Advocacy: Strategies and Success Stories BKH04-01 LauraSola Speaker solalaura11@gmail.comUruguayDialysis Center, CASMU-IAMPP How to Convince Your Health Minister to Invest in CKD Prevention BKH04-02 Elliot KorantengTannor Speaker elliotktannor@yahoo.co.ukGhanaKwame Nkrumah University of Science and Technology Toward Removal of Socioeconomic Inequities in Kidney Care and Better Outcomes for Children BKH04-03 ArpanaIyengar Speaker arpanaiyengar@gmail.comIndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE How Do We Advocate for Better Access to Kidney Transplantation Worldwide? BKH04-04 IkechiOkpechi Speaker iokpechi@ualberta.caCanadaUniversity of Alberta Q&A BKH04-05 Kumudini Hall 301
2:15 p.m. 3:45 p.m.	What’s Next in Kidney Care Research? Innovations and Clinical Trials on the Horizon SS2 AdeeraLevin Chair alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care Andrea Vichelli Chair andrea.viecelli@health.qld.gov.auAustraliaUniversity of Queensland Ajit singhNarula Chair narulaas@gmail.comIndia Novel Trial Designs in Nephrology: Innovations and Structures SS2-01 MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia What’s New in Clinical Trials? SS2-02 DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London Value of Different Outcomes in the Era of Precision Medicine SS2-03 RobertoPecoits Filho Speaker roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Conducting Trials in Low and Middle-income Countries SS2-04 SoumitaBagchi Speaker soumita_bagchi@yahoo.co.inIndiaProfessor, Department of Nephrology, All India Institute of Medical Sciences, New Delhi Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct SS2-05 ArpanaIyengar Speaker arpanaiyengar@gmail.comIndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE Q&A SS2-06 Parijat Hall 201
4:15 p.m. 5:15 p.m.	Hot Debate - The KDIGO BP Targets in CKD Are (Un)Achievable and (Un)Realistic IK05 ArpanaIyengar Chair arpanaiyengar@gmail.comIndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE BeatrizFernandez-Fernandez Chair bfernandez@fjd.esSpainHospital Universitario Fundación Jimenez Díaz Venkata DakshinamurtyKaligotla Chair kvdm1954@gmail.comIndiaMahatma Sri Ramchandra Centenary Memorial Hospital, Vijayanagar Colony, Hyderabad, INDIA Hot Debate: The KDIGO BP Targets in CKD Are Unachievable and Unrealistic - PRO IK05-01 SwapnilHiremath Speaker shiremath@toh.caCanadaUniversity of Ottawa Hot Debate: The KDIGO BP Targets in CKD Are Unachievable and Unrealistic - CON IK05-02 IndranilDasgupta Speaker Indranil.Dasgupta@uhb.nhs.ukUnited KingdomConsultant Nephrologist, University Hospitals Birmingham, UK Brahmkamal Hall - Plenary Hall